bpc 157 route of administration Dosage: A Doctor's Evidence-Based Guide BPC 157 | Gastric Pentadecapeptide

K., Simmons, D., Ahlenstiel, G

This article is for educational purposes and summarizes publicly reported regulatory developments as of July 1, 2026

WADA Prohibition The World Anti-Doping Agency classifies both peptides as prohibited substances for competitive athletes: Section S2 classification Peptide Hormones, Growth Factors, and Related Substances Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions available not recognized as legitimate medical treatments Performance-enhancing potential acknowledged due to growth hormone secretagogue effects Detection methods under development for anti-doping testing programs WADAs position reflects that these peptides possess clear performance-enhancing properties and lack approved therapeutic applications that would justify medical use exemptions

The synthesis of new fat from dietary carbohydrates